Stratec SE
XETRA:SBS

Watchlist Manager
Stratec SE Logo
Stratec SE
XETRA:SBS
Watchlist
Price: 30.6 EUR 11.07%
Market Cap: 372m EUR
Have any thoughts about
Stratec SE?
Write Note

Profitability Summary

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Past Growth

To be successful and remain in business, both growth and profitability are important and necessary. Net Income growth is often seen as a sign of a company's efficiency from an operational standpoint, but is influenced heavily by a company's goals and challenges and should therefore be assessed in conjunction with other metrics like revenue and operating income growth.

Margins

Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.

Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Earnings Waterfall
Stratec SE

Revenue
250.5m EUR
Cost of Revenue
-182.8m EUR
Gross Profit
67.8m EUR
Operating Expenses
-48.7m EUR
Operating Income
19m EUR
Other Expenses
-9m EUR
Net Income
10m EUR

Margins Comparison
Stratec SE Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
DE
Stratec SE
XETRA:SBS
362.9m EUR
27%
8%
4%
US
Abbott Laboratories
NYSE:ABT
206.5B USD
56%
17%
14%
US
Intuitive Surgical Inc
NASDAQ:ISRG
192.8B USD
67%
26%
29%
US
Stryker Corp
NYSE:SYK
148.5B USD
64%
22%
16%
US
Boston Scientific Corp
NYSE:BSX
133.8B USD
69%
18%
11%
IE
Medtronic PLC
NYSE:MDT
111B USD
65%
19%
13%
US
Becton Dickinson and Co
NYSE:BDX
65B USD
45%
14%
9%
DE
Siemens Healthineers AG
XETRA:SHL
56.7B EUR
38%
12%
8%
CN
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
326.2B CNY
64%
36%
33%
US
Edwards Lifesciences Corp
NYSE:EW
42.5B USD
79%
28%
74%
US
GE Healthcare Technologies Inc
NASDAQ:GEHC
38.1B USD
41%
13%
9%
Country DE
Market Cap 362.9m EUR
Gross Margin
27%
Operating Margin
8%
Net Margin
4%
Country US
Market Cap 206.5B USD
Gross Margin
56%
Operating Margin
17%
Net Margin
14%
Country US
Market Cap 192.8B USD
Gross Margin
67%
Operating Margin
26%
Net Margin
29%
Country US
Market Cap 148.5B USD
Gross Margin
64%
Operating Margin
22%
Net Margin
16%
Country US
Market Cap 133.8B USD
Gross Margin
69%
Operating Margin
18%
Net Margin
11%
Country IE
Market Cap 111B USD
Gross Margin
65%
Operating Margin
19%
Net Margin
13%
Country US
Market Cap 65B USD
Gross Margin
45%
Operating Margin
14%
Net Margin
9%
Country DE
Market Cap 56.7B EUR
Gross Margin
38%
Operating Margin
12%
Net Margin
8%
Country CN
Market Cap 326.2B CNY
Gross Margin
64%
Operating Margin
36%
Net Margin
33%
Country US
Market Cap 42.5B USD
Gross Margin
79%
Operating Margin
28%
Net Margin
74%
Country US
Market Cap 38.1B USD
Gross Margin
41%
Operating Margin
13%
Net Margin
9%
No Stocks Found

Return on Capital

Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.

Return on Capital Comparison
Stratec SE Competitors

Country Company Market Cap ROE ROA ROCE ROIC
DE
Stratec SE
XETRA:SBS
362.9m EUR
4%
2%
5%
3%
US
Abbott Laboratories
NYSE:ABT
206.5B USD
15%
8%
12%
10%
US
Intuitive Surgical Inc
NASDAQ:ISRG
192.8B USD
16%
14%
14%
19%
US
Stryker Corp
NYSE:SYK
148.5B USD
19%
9%
14%
11%
US
Boston Scientific Corp
NYSE:BSX
133.8B USD
9%
5%
9%
7%
IE
Medtronic PLC
NYSE:MDT
111B USD
9%
5%
8%
7%
US
Becton Dickinson and Co
NYSE:BDX
65B USD
7%
3%
6%
5%
DE
Siemens Healthineers AG
XETRA:SHL
56.7B EUR
11%
4%
8%
5%
CN
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
326.2B CNY
33%
22%
30%
37%
US
Edwards Lifesciences Corp
NYSE:EW
42.5B USD
51%
37%
16%
18%
US
GE Healthcare Technologies Inc
NASDAQ:GEHC
38.1B USD
22%
5%
10%
7%
Country DE
Market Cap 362.9m EUR
ROE
4%
ROA
2%
ROCE
5%
ROIC
3%
Country US
Market Cap 206.5B USD
ROE
15%
ROA
8%
ROCE
12%
ROIC
10%
Country US
Market Cap 192.8B USD
ROE
16%
ROA
14%
ROCE
14%
ROIC
19%
Country US
Market Cap 148.5B USD
ROE
19%
ROA
9%
ROCE
14%
ROIC
11%
Country US
Market Cap 133.8B USD
ROE
9%
ROA
5%
ROCE
9%
ROIC
7%
Country IE
Market Cap 111B USD
ROE
9%
ROA
5%
ROCE
8%
ROIC
7%
Country US
Market Cap 65B USD
ROE
7%
ROA
3%
ROCE
6%
ROIC
5%
Country DE
Market Cap 56.7B EUR
ROE
11%
ROA
4%
ROCE
8%
ROIC
5%
Country CN
Market Cap 326.2B CNY
ROE
33%
ROA
22%
ROCE
30%
ROIC
37%
Country US
Market Cap 42.5B USD
ROE
51%
ROA
37%
ROCE
16%
ROIC
18%
Country US
Market Cap 38.1B USD
ROE
22%
ROA
5%
ROCE
10%
ROIC
7%
No Stocks Found

Free Cash Flow

Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.

If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.

See Also

Discover More
Back to Top